RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases
PLOS Pathogens · 02.07.2026 · 22 (7) · e1014415
DOI: 10.1371/journal.ppat.1014415 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 02.07.2026. Verfasst von Qingxiang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology and AIDS Research, Centre of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation…. Hauptthemen laut MEDLINE: Immunity, Innate, Virus Replication, Ubiquitin-Protein Ligases, Viral Proteins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology, National Key R&D Program of China.
Abstract (Originalsprache)
A persistent evolutionary arms race exists between enteroviruses and their hosts, in which viruses employ multiple strategies to antagonize host antiviral defenses and sustain efficient replication. However, how host restriction factors are broadly targeted by enteroviruses during this process, as well as the underlying molecular mechanisms, remain poorly understood. Here, we identify ring finger protein 31 (RNF31) as a previously unrecognized host restriction factor that limits enterovirus A71 (EV-A71) replication through a dual antiviral mechanism. Specifically, RNF31 enhances innate antiviral immune signaling by promoting K63-linked polyubiquitination of Retinoic acid-inducible gene I (RIG-I). Simultaneously, RNF31 directly suppresses EV-A71 replication by inducing K27- and K48-linked polyubiquitination of the Viral Protein 4 (VP4), thereby resulting in its proteasome-dependent degradation. Furthermore, we demonstrate that the viral 3C protease (3Cpro) cleaves RNF31 at residue Q400, abolishing both RNF31-mediated activation of innate immunity and VP4 degradation, ultimately resulting in the loss of its antiviral activity. Notably, 3Cpro from multiple enteroviruses, including Coxsackievirus A16 (CV-A16), Coxsackievirus B3 (CV-B3), and Enterovirus D68 (EV-D68), cleave RNF31 at this same conserved site. Consistent with these findings, RNF31 significantly inhibits the replication of these diverse enteroviruses. Collectively, this study establishes RNF31 as a host restriction factor that suppresses the replication of multiple enteroviruses and reveals a shared immune evasion strategy employed by enteroviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Virology and AIDS Research, Centre of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, the First Hospital of Jilin University,…
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, the Second Hospital of Jilin University, Changchun, China.
ORCID-Profile: Wenyan Zhang
Förderung
- National Natural Science Foundation of China
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology
- National Key R&D Program of China
- Key Laboratory of Molecular Virology, Jilin Province
- Bethune Project, Jilin University
- Bethune Medical Department Medicine + X Interdisciplinary Innovation Team
- Outstanding PhD Student Training Program of the First Hospital of Jilin University
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
Zitieren
APA
Zhang, Q., Gao, Y., Gao, W., Zhang, X., Xu, S., & Zhang, W. (2026). RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases. PLOS Pathogens, 22(7), e1014415. https://doi.org/10.1371/journal.ppat.1014415
Vancouver
Zhang Q, Gao Y, Gao W, Zhang X, Xu S, Zhang W. RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases. PLOS Pathogens. 2026;22(7):e1014415. doi:10.1371/journal.ppat.1014415
BibTeX
@article{Zhang2026,
author = {Zhang, Qingxiang and Gao, Yuan and Gao, Wenying and Zhang, Xue and Xu, Shengyuan and Zhang, Wenyan},
title = {RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {7},
pages = {e1014415},
doi = {10.1371/journal.ppat.1014415}
}
EUVIMED